Quarterly report [Sections 13 or 15(d)]

Condensed Statements of Operations (Unaudited)

v3.25.3
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net Sales $ 1,273 $ 4,914 $ 5,704 $ 11,348
Cost of Sales (includes inventory write-downs of $1,967 for the three and nine months ended September 30, 2025) 3,533 3,490 6,715 8,494
Gross profit (loss) (2,260) 1,424 (1,011) 2,854
Operating Expenses        
Sales and marketing 198 252 642 746
Research and development 157 172 463 586
General and administrative 807 960 2,518 3,001
Impairment of right-of-use assets and lease deposits 455 455
Total operating expenses 1,617 1,384 4,078 4,333
Income (loss) from operations (3,877) 40 (5,089) (1,479)
Other income (expenses)        
Interest expense and finance costs (208) (153) (543) (496)
Other Income 126 11 347
Total other income (expenses), net (208) (27) (532) (149)
Net income (loss) $ (4,085) $ 13 $ (5,621) $ (1,628)
Net income loss per share, basic $ (1.63) $ 0.01 $ (2.24) $ (0.65)
Net income loss per share, diluted $ (1.63) $ 0.01 $ (2.24) $ (0.65)
Weighted average shares outstanding, basic 2,511,532 2,508,802 2,511,103 2,508,802
Weighted average shares outstanding, diluted 2,511,532 2,508,802 2,511,103 2,508,802